winter
eight
allerg
patient
mean
age
year
eight
nonallerg
patient
mean
age
year
clinic
symptom
common
cold
particip
studi
tabl
within
day
onset
natur
acquir
common
cold
patient
record
sever
nasal
symptom
visual
analog
scale
va
rang
mild
absent
sever
total
nasal
symptom
score
calcul
sum
five
individu
nasal
symptom
score
record
runni
nose
nasal
blockag
sneez
nasal
itch
eye
water
irrit
rang
togeth
patient
consid
common
cold
includ
studi
total
nasal
symptom
score
higher
patient
present
least
symptom
runni
nose
nasal
blockag
allerg
sensit
confirm
posit
skin
prick
test
reaction
wheal
diamet
least
vivodiagnost
alk
benelux
bv
groningen
netherland
detect
specif
serum
ige
phadiatop
pharmacia
cap
system
uppsala
sweden
mite
grass
pollen
birch
pollen
cat
dog
allergen
sensit
patient
mild
rhiniti
symptom
without
asthma
none
patient
use
topic
system
corticosteroid
previou
week
patient
gave
inform
consent
rotterdam
univers
medic
ethic
committe
approv
nasal
brush
studi
nasal
brush
sampl
taken
acut
phase
common
cold
convalesc
week
later
baselin
sampl
taken
month
common
cold
nasal
symptom
present
least
week
sampl
moment
patient
record
sever
sever
nasal
symptom
report
previous
gener
malais
va
sampl
taken
outsid
pollen
season
cell
harvest
nasal
brush
sampl
collect
previous
describ
godthelp
et
al
cell
wash
ml
rpmi
medium
life
technolog
supernat
collect
store
viral
mycoplasma
rna
isol
pcr
amplif
cell
pellet
place
ii
oct
compound
mile
inc
diagnost
divis
terrytown
ny
usa
liquid
nitrogen
frozen
section
transfer
sigma
microscop
slide
store
use
type
infect
confirm
nasal
brush
sampl
within
first
day
common
cold
respiratori
syncyti
viru
rsv
adenoviru
influenza
viru
type
b
enteroviru
parainfluenza
viru
type
infect
detect
immunofluoresc
stain
nasal
brush
cell
antivir
antibodi
viral
isol
ml
nasal
brush
supernat
rhinoviru
coronaviru
mycoplasma
pneumonia
infect
detect
amplif
viral
rna
ml
nasal
brush
supernat
follow
hybrid
either
rhinoviru
coronaviru
radiolabel
probe
slide
frozen
nasal
brush
cell
defrost
fix
aceton
min
rins
salin
pb
ph
place
semiautomat
stainer
sequenza
shandon
amsterdam
netherland
block
nonspecif
antibodi
bind
slide
incub
min
room
temperatur
normal
goat
serum
clb
dilut
pb
supplement
bovin
serum
albumin
sigma
azid
pbsbsa
subsequ
slide
incub
min
mous
antihuman
monoclon
antibodi
cell
marker
chemokin
mention
tabl
dilut
pbsbsa
slide
rins
pb
incub
min
biotinyl
goat
antimous
ig
serum
pbsbsa
plu
human
serum
rins
pb
incub
either
streptavidin
alkalin
phosphatas
pbsbsa
plu
human
serum
biogenex
klinipath
duiven
netherland
cell
type
stain
polyclon
goat
antibiotin
antibodi
pbsbsa
plu
human
serum
sigma
chemokin
stain
min
room
temperatur
section
rins
distil
water
tri
buffer
ph
incub
min
new
fuchsin
substrat
chroma
kongen
germani
final
section
counterstain
gill
hematoxylin
mount
control
stain
perform
substitut
primari
monoclon
antibodi
isotyp
control
antibodi
everi
nasal
brush
sampl
least
cell
nuclei
count
number
posit
stain
cell
calcul
percentag
cell
present
posit
stain
cell
bright
cell
membran
cytoplasm
depend
cell
type
chemokin
evalu
cell
count
magnif
statist
analysi
cell
number
perform
spss
differ
cell
count
three
sampl
moment
analyz
nonparametr
friedman
test
relat
sampl
differ
sampl
moment
consid
statist
signific
p
valu
subsequ
differ
two
sampl
moment
analyz
wilcoxon
sign
rank
test
pair
sampl
differ
allerg
nonallerg
patient
sampl
moment
measur
correl
number
cell
type
chemokin
clinic
paramet
test
spearman
correl
coeffici
differ
group
sampl
moment
consid
statist
signific
patient
investig
significantli
elev
total
nasal
symptom
score
fig
increas
symptom
gener
malais
acut
phase
common
cold
compar
convalesc
baselin
patient
viru
pneumonia
infect
confirm
tabl
acut
convalesc
phase
differ
system
local
nasal
symptom
observ
allerg
nonallerg
patient
baselin
allerg
patient
report
slightli
higher
total
nasal
symptom
score
nonallerg
patient
number
posit
stain
cell
count
per
nasal
brush
cell
nuclei
stain
dark
posit
stain
cell
red
cell
membran
cytoplasm
major
basic
protein
mbp
tryptas
eotaxin
rant
fig
show
repres
section
nasal
brush
cell
stain
eosinophil
cell
common
cold
significantli
increas
number
cell
posit
observ
compar
convalesc
baselin
sampl
fig
baselin
convalesc
gener
fewer
monocyt
macrophag
natur
killer
cell
nk
cell
detect
figur
increas
sharpli
common
cold
level
cell
present
nasal
brush
sampl
baselin
level
posit
cell
vari
consider
increas
maximum
cell
present
common
cold
fewer
cell
cell
detect
nasal
brush
sampl
rang
slight
trend
toward
increas
number
common
cold
friedman
test
fig
high
number
neutrophil
cell
observ
rang
signific
differ
observ
three
sampl
moment
fig
langerhan
cell
posit
median
rang
posit
b
cell
posit
median
rang
posit
detect
nasal
brush
sampl
differ
cell
type
mention
observ
allerg
nonallerg
patient
acut
convalesc
phase
common
cold
baselin
observ
significantli
macrophag
nonallerg
allerg
patient
acut
phase
common
cold
allerg
nonallerg
patient
significantli
increas
number
eosinophil
cell
detect
compar
baselin
differ
allerg
nonallerg
patient
observ
common
cold
baselin
howev
convalesc
allerg
patient
significantli
higher
eosinophil
level
nonallerg
patient
fig
allerg
patient
acut
phase
common
cold
increas
number
mast
cell
cell
found
compar
convalesc
baselin
fig
differ
found
nonallerg
patient
three
sampl
moment
number
mast
cell
common
cold
significantli
higher
allerg
nonallerg
patient
number
cell
increas
common
cold
compar
baselin
allerg
nonallerg
patient
fig
although
number
cell
decreas
common
cold
still
higher
number
detect
convalesc
baselin
number
cell
also
remain
elev
common
cold
differ
allerg
nonallerg
patient
number
cell
observ
three
sampl
moment
acut
phase
common
cold
sever
statist
signific
posit
correl
found
differ
cell
marker
chemokin
clinic
paramet
number
macrophag
monocyt
cell
nk
cell
correl
well
data
shown
number
cell
correl
well
cell
nk
cell
respect
also
posit
correl
number
cell
upper
respiratori
symptom
feel
gener
malais
respect
clarifi
immunolog
mechan
underli
immun
patholog
common
cold
allerg
patient
examin
differ
inflammatori
cell
type
chemokin
allerg
nonallerg
patient
nasal
brush
specimen
natur
acquir
common
cold
allerg
nonallerg
patient
show
initi
respons
macrophag
monocyt
cell
nk
cell
eosinophil
nasal
epithelium
howev
respons
observ
acut
phase
allerg
patient
addit
increas
number
eosinophil
acut
phase
persist
convalesc
allerg
patient
differ
immunolog
respons
may
underli
differ
diseas
express
common
cold
allerg
nonallerg
patient
wide
varieti
respiratori
virus
induc
common
cold
symptom
induc
airway
hyperrespons
allerg
patient
howev
almost
common
cold
studi
use
experiment
induc
infect
model
rhinoviru
type
man
allergen
provoc
studi
shown
immunolog
data
deriv
experiment
studi
differ
data
acquir
natur
occur
diseas
stress
import
studi
natur
diseas
littl
known
role
virus
rhinoviru
induc
inflammatori
respons
relat
common
cold
influx
inflammatori
cell
cell
monocyt
macrophag
nk
cell
found
studi
compar
found
common
cold
studi
allerg
patient
control
contrast
studi
observ
nasal
influx
neutrophil
sinc
high
number
neutrophil
found
nose
sampl
moment
differ
observ
allerg
nonallerg
patient
would
seem
like
neutrophil
play
role
differenti
two
patient
group
howev
function
differ
cytokin
product
may
explain
differ
airway
hyperreact
respons
studi
studi
show
increas
level
histamin
lavag
sampl
common
cold
allerg
subject
indic
role
mast
cell
airway
hyperrespons
addit
mast
cell
allergen
challeng
shown
produc
mediat
cytokin
attract
activ
eosinophil
lead
prime
subject
induct
airway
hyperrespons
howev
mediat
histamin
product
alon
result
prime
phenomena
therefor
product
like
explain
airway
hyperrespons
common
cold
allerg
diseas
like
candid
induc
immun
patholog
seem
eosinophil
although
increas
number
eosinophil
detect
nose
allerg
nonallerg
patient
common
cold
allerg
patient
eosinophilia
persist
convalesc
asthmat
patient
also
prolong
eosinophilia
found
induc
common
cold
bronchial
nasal
sampl
knowledg
observ
first
show
persist
nasal
eosinophil
respons
rel
mildli
allerg
subject
natur
acquir
common
cold
report
increas
nasal
bronchial
hyperreact
subject
allerg
rhiniti
influx
mast
cell
releas
product
persist
eosinophil
airway
mucosa
may
caus
increas
airway
hyperreact
allerg
patient
compar
nonallerg
control
contrari
expect
basi
find
differ
found
allerg
nonallerg
patient
chemokin
posit
cell
increas
cell
observ
common
cold
group
howev
eosinophil
may
display
enhanc
suscept
allerg
individu
chemokin
mention
exampl
alter
chemokin
receptor
express
mechan
increas
express
inflammatori
epitheli
cell
decreas
apoptosi
eosinophil
may
account
prolong
eosinophilia
nose
common
cold
next
step
measur
actual
quantiti
chemokin
produc
nasal
brush
cell
allerg
nonallerg
patient
conclus
increas
number
mast
cell
infect
enhanc
nasal
eosinophilia
common
cold
allerg
patient
may
explain
nasal
bronchial
hyperreact
asthma
exacerb
viral
infect
studi
need
clarifi
eosinophil
tend
persist
longer
nose
allerg
patient
nonallerg
patient
common
cold
studi
support
netherland
asthma
foundat
netherland
organ
scientif
research
